Mignat C, Jansen R, Ziegler A
Department of Pharmacology, Univeristy of Kiel, Germany.
J Pharm Pharmacol. 1995 Feb;47(2):171-5. doi: 10.1111/j.2042-7158.1995.tb05772.x.
The pharmacokinetics of morphine in plasma and the distribution of morphine and its glucuronidated metabolites within the cerebrospinal fluid were investigated in rabbits. After single morphine dosage, the plasma AUC ratio of morphine-3- glucuronide/morphine was 11.1 compared with 0.14 for morphine-6-glucuronide/morphine. The similar elimination half-lives of morphine (107 min), morphine-3-glucuronide (122 min), and morphine-6-glucuronide (105 min) suggested the glucuronidation to be the rate-limiting step, which was substantiated by the observation that morphine-3-glucuronide becomes eliminated four times faster when applied intravenously. Both after single and repeated morphine administration, the ratios of CSF and plasma levels of the parent drug were higher than those of morphine-3-glucuronide or morphine-6-glucuronide. These data demonstrate a poor penetration of the glucuronides across the blood-brain barrier and do not support the previously postulated accumulation of morphine-6-glucuronide in the central nervous system during chronic morphine treatment.
在兔子身上研究了吗啡在血浆中的药代动力学以及吗啡及其葡萄糖醛酸化代谢产物在脑脊液中的分布情况。单次给予吗啡后,吗啡 -3-葡萄糖醛酸苷/吗啡的血浆AUC比值为11.1,而吗啡 -6-葡萄糖醛酸苷/吗啡的该比值为0.14。吗啡(107分钟)、吗啡 -3-葡萄糖醛酸苷(122分钟)和吗啡 -6-葡萄糖醛酸苷(105分钟)相似的消除半衰期表明葡萄糖醛酸化是限速步骤,静脉注射时吗啡 -3-葡萄糖醛酸苷的消除速度快四倍这一观察结果证实了这一点。单次和重复给予吗啡后,母体药物的脑脊液与血浆水平比值均高于吗啡 -3-葡萄糖醛酸苷或吗啡 -6-葡萄糖醛酸苷。这些数据表明葡萄糖醛酸苷穿过血脑屏障的能力较差,并不支持先前假设的在慢性吗啡治疗期间吗啡 -6-葡萄糖醛酸苷在中枢神经系统中蓄积的观点。